BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22180281)

  • 1. [Diagnostics and treatment of hepatic encephalopathy].
    Gillmann A; Gerharz CD; Müssig K
    Dtsch Med Wochenschr; 2012 Jan; 137(1-2):29-33. PubMed ID: 22180281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy for hepatic encephalopathy.
    Phongsamran PV; Kim JW; Cupo Abbott J; Rosenblatt A
    Drugs; 2010 Jun; 70(9):1131-48. PubMed ID: 20518580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
    Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
    Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: the modern management of hepatic encephalopathy.
    Bajaj JS
    Aliment Pharmacol Ther; 2010 Mar; 31(5):537-47. PubMed ID: 20002027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hepatic encephalopathy: focus on antibiotic therapy.
    Festi D; Vestito A; Mazzella G; Roda E; Colecchia A
    Digestion; 2006; 73 Suppl 1():94-101. PubMed ID: 16498257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifaximin for the treatment of hepatic encephalopathy.
    de Melo RT; Charneski L; Hilas O
    Am J Health Syst Pharm; 2008 May; 65(9):818-22. PubMed ID: 18436728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifaximin for treatment of hepatic encephalopathy.
    Maclayton DO; Eaton-Maxwell A
    Ann Pharmacother; 2009 Jan; 43(1):77-84. PubMed ID: 19092143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatic encephalopathy].
    Häussinger D
    Praxis (Bern 1994); 2006 Oct; 95(40):1543-9. PubMed ID: 17048412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.
    Prakash RK; Kanna S; Mullen KD
    Clin Ther; 2013 Sep; 35(9):1458-73. PubMed ID: 23972578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Hepatic Encephalopathy: A Primer.
    Jawaro T; Yang A; Dixit D; Bridgeman MB
    Ann Pharmacother; 2016 Jul; 50(7):569-77. PubMed ID: 27126547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic encephalopathy.
    Häussinger D
    Acta Gastroenterol Belg; 2010; 73(4):457-64. PubMed ID: 21299155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic encephalopathy: pathophysiology and emerging therapies.
    Sundaram V; Shaikh OS
    Med Clin North Am; 2009 Jul; 93(4):819-36, vii. PubMed ID: 19577116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal treatment of hepatic encephalopathy.
    Waghray A; Waghray N; Kanna S; Mullen K
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):55-70. PubMed ID: 24632768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):27-32. PubMed ID: 20133225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic encephalopathy in dogs and cats.
    Lidbury JA; Cook AK; Steiner JM
    J Vet Emerg Crit Care (San Antonio); 2016 Jul; 26(4):471-87. PubMed ID: 27060899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatic encephalopathy].
    Häussinger D; Kircheis G
    Praxis (Bern 1994); 2002 May; 91(22):957-63. PubMed ID: 12094429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatic encephalopathy and liver transplantation].
    Fehérvári I; Nemes B; Görög D; Gerlei Z; Kóbori L
    Magy Seb; 2012 Apr; 65(2):58-62. PubMed ID: 22512880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms, diagnosis and management of hepatic encephalopathy.
    Prakash R; Mullen KD
    Nat Rev Gastroenterol Hepatol; 2010 Sep; 7(9):515-25. PubMed ID: 20703237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatic encephalopathy: recent developments].
    Deltenre P; Moradpour D
    Rev Med Suisse; 2014 Sep; 10(440):1612, 1614-6. PubMed ID: 25277000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covert Hepatic Encephalopathy: Who Should Be Tested and Treated?
    Flamm SL
    Clin Liver Dis; 2015 Aug; 19(3):473-85. PubMed ID: 26195202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.